These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 17167543)
1. The Wilms tumour suppressor protein WT1 (+KTS isoform) binds alpha-actinin 1 mRNA via its zinc-finger domain. Morrison AA; Venables JP; Dellaire G; Ladomery MR Biochem Cell Biol; 2006 Oct; 84(5):789-98. PubMed ID: 17167543 [TBL] [Abstract][Full Text] [Related]
2. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one. Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038 [TBL] [Abstract][Full Text] [Related]
3. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells. Han Y; San-Marina S; Yang L; Khoury H; Minden MD Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147 [TBL] [Abstract][Full Text] [Related]
4. Kinetic behaviour of WT 1's zinc finger domain in binding to the alpha-actinin-1 mRNA. Nurmemmedov E; Yengo RK; Ladomery MR; Thunnissen MM Arch Biochem Biophys; 2010 May; 497(1-2):21-7. PubMed ID: 20193655 [TBL] [Abstract][Full Text] [Related]
5. New insights into DNA-binding behavior of Wilms tumor protein (WT1)--a dual study. Nurmemmedov E; Yengo RK; Uysal H; Karlsson R; Thunnissen MM Biophys Chem; 2009 Dec; 145(2-3):116-25. PubMed ID: 19853363 [TBL] [Abstract][Full Text] [Related]
6. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers. Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984 [TBL] [Abstract][Full Text] [Related]
7. A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system. Wagner N; Wagner KD; Hammes A; Kirschner KM; Vidal VP; Schedl A; Scholz H Development; 2005 Mar; 132(6):1327-36. PubMed ID: 15716344 [TBL] [Abstract][Full Text] [Related]
8. The ratio of +/-KTS splice variants of the Wilms' tumour suppressor protein WT1 mRNA is determined by an intronic enhancer. Yang C; Romaniuk PJ Biochem Cell Biol; 2008 Aug; 86(4):312-21. PubMed ID: 18756326 [TBL] [Abstract][Full Text] [Related]
9. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells. Menke AL; Riteco N; van Ham RC; de Bruyne C; Rauscher FJ; van der Eb AJ; Jochemsen AG Oncogene; 1996 Feb; 12(3):537-46. PubMed ID: 8637710 [TBL] [Abstract][Full Text] [Related]
10. WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo. Markus MA; Heinrich B; Raitskin O; Adams DJ; Mangs H; Goy C; Ladomery M; Sperling R; Stamm S; Morris BJ Exp Cell Res; 2006 Oct; 312(17):3379-88. PubMed ID: 16934801 [TBL] [Abstract][Full Text] [Related]
11. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor. Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658 [TBL] [Abstract][Full Text] [Related]
12. RNA Binding by the KTS Splice Variants of Wilms' Tumor Suppressor Protein WT1. Nishikawa T; Wojciak JM; Dyson HJ; Wright PE Biochemistry; 2020 Oct; 59(40):3889-3901. PubMed ID: 32955251 [TBL] [Abstract][Full Text] [Related]
13. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways. Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666 [TBL] [Abstract][Full Text] [Related]
14. The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties. Kim J; Lee K; Pelletier J Oncogene; 1998 Apr; 16(15):1973-9. PubMed ID: 9591781 [TBL] [Abstract][Full Text] [Related]
15. Wilms tumor and the WT1 gene. Lee SB; Haber DA Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1. Cook DM; Hinkes MT; Bernfield M; Rauscher FJ Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526 [TBL] [Abstract][Full Text] [Related]
17. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1. Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912 [TBL] [Abstract][Full Text] [Related]
18. Distinct global binding patterns of the Wilms tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells. Ullmark T; Järvstråt L; Sandén C; Montano G; Jernmark-Nilsson H; Lilljebjörn H; Lennartsson A; Fioretos T; Drott K; Vidovic K; Nilsson B; Gullberg U Haematologica; 2017 Feb; 102(2):336-345. PubMed ID: 27612989 [TBL] [Abstract][Full Text] [Related]
19. DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and -KTS isoforms-From initial observations to recent global genomic analyses. Ullmark T; Montano G; Gullberg U Eur J Haematol; 2018 Mar; 100(3):229-240. PubMed ID: 29240258 [TBL] [Abstract][Full Text] [Related]
20. Presence of WT1 in nuclear messenger RNP particles in the human acute myeloid leukemia cell lines HL60 and K562. Morrison AA; Ladomery MR Cancer Lett; 2006 Nov; 244(1):136-41. PubMed ID: 16457949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]